NCT00674947 (Clinical Trial/ BIIB015)

Study Title
A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors (NCT00674947)
Trial Description
Phase 1, open-labeled, safety and tolerability study for the treatment of subjects with relapsed or refractory solid tumors.

This trial is sponsored by Biogen. [1]

Study Data

  • Condition: Solid Tumors
  • Interventions:
    • Drugs used in this trial
      • BIIB015
  • Phase: I
  • Enrollment: 55
  • Start: June 2008
  • Completion: June 2011
  • Last verified: September 2011

Study Schematic

(Coming soon)

Click here to Return to Drug map

Last Editorial review: September 29, 2015
Information based on (NIH/NCI) and other sources.